Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of intravenous (IV)
carbamazepine (CBZ) administered as multiple 15 minute infusions and a single 5 minute
infusion to adult patients with epilepsy on stable higher doses of oral CBZ.
Phase:
Phase 3
Details
Lead Sponsor:
Lundbeck LLC
Collaborators:
ICON Clinical Research Ligand Pharmaceuticals Quintiles, Inc.